As a result of this program, learners will be able to discuss current and new developments with HIV anti-retrovirals (ARVs) and the use of ARVs in Pre-Exposure Prophylaxis (PrEP)
Program Objectives:
- Explain the patho-physiology of HIV and identify current options for treatment naive HIV
- Explain non-traditional dual ARV combination therapy
- Discuss new developments in pre-exposure prophylaxis (PrEP)
Speaker:
Meera Mehta, PharmD
PGY2 Infectious Disease Pharmacy Resident
Adjunct Professor
West Virginia University School of Medicine